Bloody Minded cover image

Episode 106 - Seal Team L | Chronic Lymphocytic Leukaemia (CLL)

Bloody Minded

00:00

Modern Targeted CLL Therapies

Bash and Alison describe the shift from chemoimmunotherapy to anti-CD20 antibodies, BTK inhibitors, venetoclax, and continuous or fixed-duration regimens.

Play episode from 32:32
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app